Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
BiomX Provides a Program Update and Announces New FDA Feedback Potentially Expanding BX004 Development Pathways
-
PharmaTher Applauds FDA's Commissioner's National Priority Voucher (CNPV) Selection of Ketamine; Company Highlights Potential Ketamine Opportunity, 505(b)(2) Focus, and Upside from Strategic ANDA Sale
-
Kyle Forgeard Endorses Amino on Instagram Following a Strong First Month for the AI Calorie Counter App
-
Metallus Announces Third-Quarter 2025 Earnings Webcast Details
-
Patented Innovation Empowers Home Creators Delivering Professional Customization with Simplified Operation and Friendly Pricing
-
Simplilearn Named to 2026 GSV 150: Recognized Among the World's Most Transformational Growth Companies in Digital Learning & Workforce Skills
-
Innerspace Counseling Welcomes Ira Hays, LCSW, as Director of Clinical Services
-
Push Digits Redefines Affordability in Finance: Making Top-Tier Accounting Services Accessible for SMEs
-
Dream Exchange CEO Joe Cecala to Host Follow-Up Webinar on New Report
-
Search Minerals Appoints Chief Financial Officer
-
Evaxion reports 75% Objective Response Rate in phase 2 trial with AI-designed personalized cancer vaccine EVX-01
-
Mainscape CEO Mark Forsythe Highlights Employee-First Vision and Future Employee Centered Model
-
Avanzanite Bioscience’s Partner Agios Announces Positive CHMP Opinion for PYRUKYND® (mitapivat) for Adults with Thalassemia
-
MEDIA ADVISORY - MDA SPACE TO HOLD ITS THIRD QUARTER 2025 EARNINGS CONFERENCE CALL ON NOVEMBER 14, 2025
-
Marcus & Millichap, Inc. to Report Third Quarter 2025 Financial Results on Friday, November 7, 2025
-
Royalty Pharma Declares Fourth Quarter 2025 Dividend
-
Rockhaven Resources Ltd. Appoints Axemen Resource Capital As Financial Advisor and Grants an Incentive Stock Option and RSUs
-
City of Santa Fe Springs Announces Innovative Business Growth & Attraction Program
-
IMFINZI® (durvalumab) regimen reduced the risk of disease recurrence or death by 32% in high-risk non-muscle-invasive bladder cancer in the POTOMAC Phase III trial
-
IMUNON Invited to Present PlaCCine® DNA Technology Proof-of-Concept Data in Platform Presentations at Leading Vaccine Conferences
-
Kalma Capital Corp. Announces Resignation of Director
-
Proven Strength, New Chapters Ahead: Chery Super Hybrid (CSH) Global Endurance Test Concludes in Triumph, Paving the Way for the 2025 Chery Brand User Summit
-
Bybit x Block Scholes Quarterly Report: Rise of Perp DEXs -- and How to Catch the Opportunity
-
Savara Announces Chief Medical Officer (CMO) Transition
-
Butterfly Network to Report Third Quarter 2025 Financial Results on October 31, 2025
-
Home Trends & Design Announces Strategic Alliance with FurnitureDealer.net
-
Samsung Electronics Completes Acquisition of Xealth, Accelerating Connected Care
-
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Heidrick & Struggles International, Inc. (Nasdaq - HSII), Comerica Incorporated (NYSE - CMA), Veeco Instruments
-
ClearNote Health to Showcase Latest Advancements in Early Cancer Detection Testing at ESMO Congress 2025
-
Iconic Announces Equity Financing up to $2,550,000
-
Sphere 3D Announces a Warrant Inducement Transaction for $4.0 Million in Gross Proceeds
-
Agios’ PYRUKYND® (mitapivat) Receives Positive CHMP Opinion for Adults with Thalassemia
-
Alta and Poshmark Announce Partnership to Bring AI Shopping and Virtual Try-On to Secondhand and Vintage Fashion Enthusiasts
-
Family-Owned Danish Brand Sees Explosive U.S. Growth - Without Outside Investors
-
Perimeter Medical Imaging AI to Participate in the Planet MicroCap Showcase in Toronto
-
Leidos and VML debut Imperium™, new AI-powered platform to enhance U.S. strategic information operations
-
Vertiv to Participate in Upcoming Investor Conference
-
Visteon Declares Quarterly Dividend of $0.275 Per Share
-
Manitoba Farmers: Safely Dispose of Unwanted Pesticides and Old Livestock/Equine Medications This October
-
DeFi Technologies to Attend the 2025 Maxim Growth Summit
-
Paramount to Report Third Quarter 2025 Financial Results on November 10, 2025
-
PIRELLI: CYBER TYRE AWARDED AS THE MOST INNOVATIVE TIRE TECHNOLOGY AT THE AUTOTECH BREAKTHROUGH AWARDS 2025
-
Hingham Public Schools to Break Ground on New Electric School Bus Project
-
Rental affordability reaches four-year high
-
Volition Donates Nu.Q® Vet Cancer Tests to HOPE Animal-Assisted Crisis Response Dogs
-
Lilly's Verzenio® (abemaciclib) prolonged survival in HR+, HER2-, high-risk early breast cancer with two years of treatment
-
Total Energy Services Inc. Plans To Repurchase Shares
-
ID.me and Flexpa Partner to Give Patients Trusted Access to Their Health Data, Fight AI-Driven Fraud, and Advance Healthcare Interoperability
-
BANCFIRST CORPORATION REPORTS THIRD QUARTER EARNINGS
-
Marengo Presents Initial Phase 2 Results Demonstrating Broad Single-Agent Activity of Invikafusp Alfa Across Multiple PD-1-Refractory or -Resistant Solid Tumors as a Late-Breaking Oral Presentation at
